Press releases
- Press releases
- Browse
Press releases
Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
London UK, 11 April 2012 - Based on its recent analysis of the responsive polymer for bio-medical application market, Frost & Sullivan recognises CIS Pharma with the 2011 European Frost & Sullivan Technology Innovation Award for its unique Cellophil™ bio- More
New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004. More
Michael Gamlen will be hosting a live demonstration and launch event at the Institute of Directors, London, on 17th March to unveil the Gamlen Tablet Press. More
We have two good condition units, worth for value:
1. Complete bioBubble system of dimension 2m W x 3m L x 2.5m H (Big – RM24,500)
2. Complete Biobubble freestanding cleanroom system of dimension
1.2m W x 1m L x 2.5m H (Small – RM15,0 More
1. Complete bioBubble system of dimension 2m W x 3m L x 2.5m H (Big – RM24,500)
2. Complete Biobubble freestanding cleanroom system of dimension
1.2m W x 1m L x 2.5m H (Small – RM15,0 More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund. More
The research area of health care is front and centre this year as two top scientists share the spotlight as winners of the 2010 Hellmuth Prize for Achievement in Research. More
Z-Cube, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd. Sign a Licensing Agreement for the Development of an Innovative Nanotechnology Drug Delivery System for the Treatment of Pain More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 124 pages - $1,740
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Jun 2009 - 472 pages - $3,140
Jun 2008 - 175 pages - $3,835
Nov 2010 - 428 pages - $2,695
Oct 2010 - 97 pages - $3,835
Apr 2007 - 118 pages - $2,495
Dec 2009 - 84 pages - $7,600
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us